" class="no-js "lang="en-US"> Drug Development Archives - Page 2 of 32 - Medtech Alert
Tuesday, March 21, 2023

Sort by:


Top Post

Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS

Accord Healthcare, a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral […]

Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

Pfizer has announced the US Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the […]

AnnJi Pharmaceutical Announced a Licensing Agreement With Avenue Therapeutics For The Treatment Of Kennedy's Disease

AnnJi Pharmaceutical has entered into an exclusive license agreement with Avenue Therapeutics for the development and […]

AusperBio Announces First-in-Human Dosing of AHB-137, an Antisense Oligonucleotide Drug Candidate for the Treatment of Chronic Hepatitis B

AusperBio has announced the completion of the first cohort dosing in a Phase 1 clinical […]

FDA Accepts Supplemental New Drug Application for Jardiance® for Children 10 years and Older with Type 2 Diabetes

The U.S. Food and Drug Administration (FDA) accepted a supplemental New Drug Application (sNDA) for […]

Sparrow Pharmaceuticals Expands Phase 2 Clinical Trial of SPI-62 with Prednisolone for Polymyalgia Rheumatica with Second Cohort

Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs […]

Personalis Selected for Clinical Research by AstraZeneca After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay

Personalis, a leader in advanced genomics for precision oncology, today announced it will continue its […]

FDA Accepts for Priority Review ADX-2191 New Drug Application for the Treatment of Primary Vitreoretinal Lymphoma

Aldeyra Therapeutics has announced that the US Food and Drug Administration (FDA) accepted for Priority […]

Pharmapack 2023 a Pivotal Moment for Sustainability in Drug Delivery and Packaging

Pharmapack Europe 2023 (February 1-2, 2023) closed earlier this month with the drug delivery and packaging […]

  1. Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
  2. Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
  3. BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
  4. Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
  5. GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more